ANTICANCER CONJUGATE BASED ON HUMAN SERUM ALBUMIN FOR IMAGING AND COMBINED THERAPY OF GLIOBLASTOMAS
2024-05-02
专利权人NANOTECH TO LLC (NANO-Non-standard)
申请日期2024-05-02
专利号RU2835210-C1
成果简介NOVELTY - Present invention relates to biotechnology and can be used in medicine. Invention discloses an anticancer conjugate based on human serum albumin with structural formula HSA-Cy5-HcyCo(B9C2H11)2-MMAE or HSA-Cy5-HcyCo(B9C2H11)2-MMAF, having in its composition a contrast agent and a boron-containing agent, as well as a chemotherapeutic agent (MMAE or MMAF) attached to the HSA through a linker, which is cleaved in the lysosome of the tumour cell. USE - Biotechnology. ADVANTAGE - Invention can be used in diagnosing and treating human glioblastomas. 1 cl, 4 dwg, 1 tbl, 4 ex
IPC 分类号A61K-047/42 ; A61P-035/00 ; C07K-014/765
国家俄罗斯
专业领域生物科学
语种英语
成果类型专利
文献类型科技成果
条目标识符http://119.78.100.226:8889/handle/3KE4DYBR/16927
专题中国科学院新疆生态与地理研究所
作者单位
NANOTECH TO LLC (NANO-Non-standard)
推荐引用方式
GB/T 7714
AVRAMCHUK T V,MEILI V,ZAKHAROVA O D,et al. ANTICANCER CONJUGATE BASED ON HUMAN SERUM ALBUMIN FOR IMAGING AND COMBINED THERAPY OF GLIOBLASTOMAS. RU2835210-C1[P]. 2024.
条目包含的文件
条目无相关文件。
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。